The Technical Analyst
Select Language :
Inovio Pharmaceuticals [INO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Inovio Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Inovio Pharmaceuticals is listed at the  Exchange

8.62% $14.15

America/New_York / 28 mar 2024 @ 10:52


Inovio Pharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 330.76 mill
EPS: -6.09
P/E: -2.32
Earnings Date: May 07, 2024
SharesOutstanding: 23.37 mill
Avg Daily Volume: 0.543 mill
RATING 2024-03-27
B-
Neutral
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Sell
DE: Buy
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.32 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.39x
Company: PE -2.32 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-1.513
(-110.69%) $-15.67
Date: 2024-03-28
Expected Trading Range (DAY)

$ 13.25 - 15.02

( +/- 6.26%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-26 Weiner David B. Buy 972 Common Stock
2024-02-26 Weiner David B. Buy 972 Common Stock
2024-02-26 Weiner David B. Buy 972 Common Stock
2024-02-26 Weiner David B. Sell 972 Restricted Stock Unit
2024-02-26 Weiner David B. Sell 972 Restricted Stock Unit
INSIDER POWER
61.29
Last 100 transactions
Buy: 3 683 868 | Sell: 932 723

Forecast: 12:31 - $14.03

Live Trading Signals (every 1 min)

Forecast 1: 11:01 - $14.10
Forecast 2: 11:51 - $14.09
Forecast 3: 12:31 - $14.03
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $14.15 (8.62% )
Volume 0.200 mill
Avg. Vol. 0.543 mill
% of Avg. Vol 36.87 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Inovio Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Inovio Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Inovio Pharmaceuticals Inc

Last 10 Buy & Sell Signals For INO

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:33sell$5.81N/AActive
Profile picture for
            Inovio Pharmaceuticals Inc

INO

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

Last 10 Buy Signals

Date Signal @
ZMar 28 - 10:50$49.62
HATUSDMar 28 - 10:483 645.29
MARMar 28 - 10:49$253.38
CINFMar 28 - 10:47$123.60
AKAMMar 28 - 10:45$109.56
HONMar 28 - 10:43$205.28
DBXMar 28 - 10:40$24.41
TXNMar 28 - 10:33$174.25
^DJIMar 28 - 10:32PTS39 723
RNDRUSDMar 28 - 10:2811.00

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.